High-quality testing

Assay coverage

Invitae is a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical diagnostic laboratory, offering panel and single gene genetic tests as well as exome analysis.

Panels and genes

Invitae's assay for panel and single gene tests includes both full-gene sequencing and deletion/duplication analysis using next-generation sequencing technology (NGS).

  • Full-gene sequencing: Covers clinically important regions of each gene including coding exons, 10 to 20 base pairs of adjacent intronic sequence on either side of the coding exons, and select noncoding variants. Any variants that fall outside these regions are not analyzed. For some genes, analysis may extend to the promoter region, include additional intronic variants, or be limited to targeted variants or exons. To request details on a specific gene(s) coverage, contact our clinical team at clinconsult@invitae.com or 800-436-3037.
  • Deletion/duplication analysis: Detects intragenic deletions and duplications at single exon resolution. However, in rare situations, single-exon copy number events may not be analyzed due to inherent sequence properties or isolated reduction in data quality.
  • Coverage: Provides an average coverage depth of at least 350x.
  • Confirmation: Using orthogonal technologies, Invitae confirms clinically all significant findings that do not meet stringent NGS quality metrics.

Download our High-quality genetic testing, simplified flyer to learn more about Invitae's commitment to delivering high-quality, affordable testing.

RNA testing

Invitae has incorporated supplemental RNA testing into the variant classification process for variants of uncertain significance (VUS). We will be analyzing VUS that are predicted to affect splicing and have been identified in a gene from any of our hereditary cancer panels.  

An amended report may be issued if the supplemental RNA data contributes to a reclassification of a VUS in your patient’s report.

As always, Invitae is dedicated to utilizing the very latest variant interpretation techniques to better understand the clinical impact of each variant identified by our genetic tests. 


Invitae's boosted exome analysis utilizes advanced next-generation sequencing (NGS) capture technology with boosted coverage of medically relevant genes. Customized capture baits enhance the coverage of hard-to-sequence areas of the exome and allow detection of intragenic copy number variants.

To learn more about Invitae's exome analysis, please refer to the Technical description section of the Exome page.

Informing medical care with genetic insights

Our team of genetic counselors, medical geneticists, and scientists works together to provide you with a curated genetic testing menu and clinically relevant test results.

  • Invitae's team of scientists extensively reviews the literature and public database entries for each gene.
  • Genetic disorders associated with each gene are analyzed, including disease penetrance, inheritance, and known pathogenic variants.
  • Each gene's molecular characteristics are defined, including known isoforms, detailed gene structures, and challenging regions to assay.
  • After review, genes are organized into panels that help you order a genetic test that matches your patient's clinical presentation.
  • During report signout, our clinical team follows the American College of Medical Genetics (ACMG) guidelines for variant classification.

Learn more about Invitae's commitment to quality

A new gold standard

Learn more

Validation studies

Learn more

Variant classification

Learn more